1. Home
  2. ATYR vs ALOT Comparison

ATYR vs ALOT Comparison

Compare ATYR & ALOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.73

Market Cap

79.2M

Sector

Health Care

ML Signal

HOLD

Logo AstroNova Inc.

ALOT

AstroNova Inc.

HOLD

Current Price

$8.14

Market Cap

56.7M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATYR
ALOT
Founded
2005
1969
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Computer peripheral equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
79.2M
56.7M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
ATYR
ALOT
Price
$0.73
$8.14
Analyst Decision
Buy
Analyst Count
6
0
Target Price
$8.75
N/A
AVG Volume (30 Days)
2.2M
30.0K
Earning Date
11-06-2025
12-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$190,000.00
$150,340,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$18,728.88
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.64
$6.96
52 Week High
$7.29
$13.83

Technical Indicators

Market Signals
Indicator
ATYR
ALOT
Relative Strength Index (RSI) 41.71 51.81
Support Level $0.70 $7.61
Resistance Level $0.83 $8.30
Average True Range (ATR) 0.05 0.39
MACD 0.01 0.14
Stochastic Oscillator 26.75 63.93

Price Performance

Historical Comparison
ATYR
ALOT

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

About ALOT AstroNova Inc.

AstroNova Inc designs, develops, manufactures, and distributes a broad range of specialty printers and data acquisition and analysis systems, including both hardware and software, which incorporate technologies to acquire, store, analyze, and present data in multiple formats sold under the QuickLabel, TrojanLabel and GetLabels brand names. Its target markets for hardware and software products include aerospace, apparel, automotive, avionics, chemicals, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging, and transportation. It has two segments, Product Identification (PI) and Test & Measurement (T&M). It generates the majority of its revenue from the PI segment that includes specialty printing systems and related supplies.

Share on Social Networks: